Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ravna, AW; Sylte, I; Dahl, SG
   Molecular model of the Escherichia coli Na-1/H-1 antiporter NhaA
   RECEPTORS & CHANNELS
   
   A.W. Ravna et al., "Molecular model of the Escherichia coli Na-1/H-1 antiporter NhaA", RECEPT CHAN, 7(4), 2001, pp. 319-328
2. Bergstrom, KA; Tupala, E; Tiihonen, J
   Dopamine transporter in vitro binding and in vivo imaging in the brain
   PHARMACOLOGY & TOXICOLOGY
   
   K.A. Bergstrom et al., "Dopamine transporter in vitro binding and in vivo imaging in the brain", PHARM TOX, 88(6), 2001, pp. 287-293
3. Dutta, AK; Reith, MEA; Madras, BK
   Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter
   SYNAPSE
   
   A.K. Dutta et al., "Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter", SYNAPSE, 39(2), 2001, pp. 175-181
4. Booij, J; Reneman, L; Lavalaye, J; Knol, RJJ; de Bruin, K; Speelman, JD; Janssen, AGM
   Dopamine transporter imaging as an in vivo marker of dopaminergic neurons
   DRUGS OF THE FUTURE
   
   J. Booij et al., "Dopamine transporter imaging as an in vivo marker of dopaminergic neurons", DRUG FUTURE, 26(3), 2001, pp. 271-279
5. Claffey, DJ; Stout, PR; Ruth, JA
   H-3-nicotine, H-3-flunitrazepam, and H-3-cocaine incorporation into melanin: A model for the examination of drug-melanin interactions
   JOURNAL OF ANALYTICAL TOXICOLOGY
   
   D.J. Claffey et al., "H-3-nicotine, H-3-flunitrazepam, and H-3-cocaine incorporation into melanin: A model for the examination of drug-melanin interactions", J ANAL TOX, 25(7), 2001, pp. 607-611
6. Borges, CR; Wilkins, DG; Rollins, DE
   Amphetamine and N-acetylamphetamine incorporation into hair: An investigation of the potential role of drug basicity in hair color bias
   JOURNAL OF ANALYTICAL TOXICOLOGY
   
   C.R. Borges et al., "Amphetamine and N-acetylamphetamine incorporation into hair: An investigation of the potential role of drug basicity in hair color bias", J ANAL TOX, 25(4), 2001, pp. 221-227
7. Adkins, EM; Barker, EL; Blakely, RD
   Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition
   MOLECULAR PHARMACOLOGY
   
   E.M. Adkins et al., "Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition", MOLEC PHARM, 59(3), 2001, pp. 514-523
8. Gether, U; Norregaard, L; Loland, CJ
   Delineating structure-function relationships in the dopamine transporter from natural and engineered Zn2+ binding sites
   LIFE SCIENCES
   
   U. Gether et al., "Delineating structure-function relationships in the dopamine transporter from natural and engineered Zn2+ binding sites", LIFE SCI, 68(19-20), 2001, pp. 2187-2198
9. Kamdar, G; Penado, KMY; Rudnick, G; Stephan, MM
   Functional role of critical stripe residues in transmembrane span 7 of theserotonin transporter - Effects of Na+, Li+, and methanethiosulfonate reagents
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   G. Kamdar et al., "Functional role of critical stripe residues in transmembrane span 7 of theserotonin transporter - Effects of Na+, Li+, and methanethiosulfonate reagents", J BIOL CHEM, 276(6), 2001, pp. 4038-4045
10. Androutsellis-Theotokis, A; Ghassemi, F; Rudnick, G
    A conformationally sensitive residue on the cytoplasmic surface of serotonin transporter
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A. Androutsellis-Theotokis et al., "A conformationally sensitive residue on the cytoplasmic surface of serotonin transporter", J BIOL CHEM, 276(49), 2001, pp. 45933-45938
11. Lopez-Corcuera, B; Nunez, E; Martinez-Maza, R; Geerlings, A; Aragon, C
    Substrate-induced conformational changes of extracellular loop 1 in the glycine transporter GLYT2
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    B. Lopez-Corcuera et al., "Substrate-induced conformational changes of extracellular loop 1 in the glycine transporter GLYT2", J BIOL CHEM, 276(46), 2001, pp. 43463-43470
12. Runkel, F; Bruss, M; Nothen, MM; Stober, G; Propping, P; Bonisch, H
    Pharmacological properties of naturally occurring variants of the human norepinephrine transporter
    PHARMACOGENETICS
    
    F. Runkel et al., "Pharmacological properties of naturally occurring variants of the human norepinephrine transporter", PHARMACOGEN, 10(5), 2000, pp. 397-405
13. Van Kampen, JM; McGeer, EG; Stoessl, AJ
    Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
    SYNAPSE
    
    J.M. Van Kampen et al., "Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity", SYNAPSE, 37(3), 2000, pp. 171-178
14. Kidwell, DA; Lee, EH; DeLauder, SF
    Evidence for bias in hair testing and procedures to correct bias
    FORENSIC SCIENCE INTERNATIONAL
    
    D.A. Kidwell et al., "Evidence for bias in hair testing and procedures to correct bias", FOREN SCI I, 107(1-3), 2000, pp. 39-61
15. Claffey, DJ; Stout, PR; Ruth, JA
    A comparison of sodium hydroxide and sodium sulfide digestion of mouse hair in the recovery of radioactivity following systemic administration of [H-3]-nicotine and [H-3]-flunitrazepam
    JOURNAL OF ANALYTICAL TOXICOLOGY
    
    D.J. Claffey et al., "A comparison of sodium hydroxide and sodium sulfide digestion of mouse hair in the recovery of radioactivity following systemic administration of [H-3]-nicotine and [H-3]-flunitrazepam", J ANAL TOX, 24(1), 2000, pp. 54-58
16. Stout, PR; Ruth, JA
    Histologic localization of serum constituents, Ca-45(2+), Cl-36(-), [C-14]urea, and [S-35]cysteine in forming hair after systemic administration
    DRUG METABOLISM AND DISPOSITION
    
    P.R. Stout e J.A. Ruth, "Histologic localization of serum constituents, Ca-45(2+), Cl-36(-), [C-14]urea, and [S-35]cysteine in forming hair after systemic administration", DRUG META D, 28(2), 2000, pp. 113-117
17. Corera, AT; Costentin, J; Bonnet, JJ
    Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    A.T. Corera et al., "Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements", N-S ARCH PH, 362(3), 2000, pp. 213-221
18. Lee, SH; Chang, MY; Lee, KH; Park, BS; Lee, YS; Chin, HR; Lee, YS
    Importance of valine at position 152 for the substrate transport and 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane binding of dopamine transporter
    MOLECULAR PHARMACOLOGY
    
    S.H. Lee et al., "Importance of valine at position 152 for the substrate transport and 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane binding of dopamine transporter", MOLEC PHARM, 57(5), 2000, pp. 883-889
19. Nakahara, Y; Hanajiri, R
    Hair analysis for drugs of abuse XXI. Effect of para-substituents on benzene ring of methamphetamine on drug incorporation into rat hair
    LIFE SCIENCES
    
    Y. Nakahara e R. Hanajiri, "Hair analysis for drugs of abuse XXI. Effect of para-substituents on benzene ring of methamphetamine on drug incorporation into rat hair", LIFE SCI, 66(7), 2000, pp. 563-574
20. Robarge, MJ; Agoston, GE; Izenwasser, S; Kopajtic, T; George, C; Katz, JL; Newman, AH
    Highly selective chiral N-substituted 3 alpha-[bis(4 '-fluorophenyl)methoxy]tropane analogues for the dopamine transporter: Synthesis and comparativemolecular field analysis
    JOURNAL OF MEDICINAL CHEMISTRY
    
    M.J. Robarge et al., "Highly selective chiral N-substituted 3 alpha-[bis(4 '-fluorophenyl)methoxy]tropane analogues for the dopamine transporter: Synthesis and comparativemolecular field analysis", J MED CHEM, 43(6), 2000, pp. 1085-1093
21. Hoepping, A; Johnson, KM; George, C; Flippen-Anderson, J; Kozikowski, AP
    Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and Stille coupling - Switch of activity toward the serotoninand/or norepinephrine transporter
    JOURNAL OF MEDICINAL CHEMISTRY
    
    A. Hoepping et al., "Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and Stille coupling - Switch of activity toward the serotoninand/or norepinephrine transporter", J MED CHEM, 43(10), 2000, pp. 2064-2071
22. Chen, NH; Reith, MEA
    Structure and function of the dopamine transporter
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    N.H. Chen e M.E.A. Reith, "Structure and function of the dopamine transporter", EUR J PHARM, 405(1-3), 2000, pp. 329-339
23. Norregaard, L; Visiers, I; Loland, CJ; Ballesteros, J; Weinstein, H; Gether, U
    Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites
    BIOCHEMISTRY
    
    L. Norregaard et al., "Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites", BIOCHEM, 39(51), 2000, pp. 15836-15846
24. Booij, J; Tissingh, G; Winogrodzka, A; van Royen, EA
    Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    J. Booij et al., "Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism", EUR J NUCL, 26(2), 1999, pp. 171-182
25. Barker, EL; Moore, KR; Rakhshan, F; Blakely, RD
    Transmembrane domain I contributes to the permeation pathway for serotoninand ions in the serotonin transporter
    JOURNAL OF NEUROSCIENCE
    
    E.L. Barker et al., "Transmembrane domain I contributes to the permeation pathway for serotoninand ions in the serotonin transporter", J NEUROSC, 19(12), 1999, pp. 4705-4717
26. Stout, PR; Ruth, JA
    Deposition of [H-3]cocaine, [H-3]nicotine, and [H-3]flunitrazepam in mousehair melanosomes after systemic administration
    DRUG METABOLISM AND DISPOSITION
    
    P.R. Stout e J.A. Ruth, "Deposition of [H-3]cocaine, [H-3]nicotine, and [H-3]flunitrazepam in mousehair melanosomes after systemic administration", DRUG META D, 27(6), 1999, pp. 731-735
27. Paczkowski, FA; Bryan-Lluka, LJ; Porzgen, P; Bruss, M; Bonisch, H
    Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    F.A. Paczkowski et al., "Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters", J PHARM EXP, 290(2), 1999, pp. 761-767
28. Eshleman, AJ; Carmolli, M; Cumbay, M; Martens, CR; Neve, KA; Janowsky, A
    Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    A.J. Eshleman et al., "Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type", J PHARM EXP, 289(2), 1999, pp. 877-885
29. Berfield, JL; Wang, LJC; Reith, MEA
    Which form of dopamine is the substrate for the human dopamine transporter: The cationic or the uncharged species?
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    J.L. Berfield et al., "Which form of dopamine is the substrate for the human dopamine transporter: The cationic or the uncharged species?", J BIOL CHEM, 274(8), 1999, pp. 4876-4882
30. Loland, CJ; Norregaard, L; Gether, U
    Defining proximity relationships in the tertiary structure of the dopaminetransporter - Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn2+-binding site
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    C.J. Loland et al., "Defining proximity relationships in the tertiary structure of the dopaminetransporter - Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn2+-binding site", J BIOL CHEM, 274(52), 1999, pp. 36928-36934
31. NEWMAN AH
    NOVEL DOPAMINE TRANSPORTER LIGANDS - THE STATE-OF-THE-ART
    Medicinal chemistry research
    
    A.H. Newman, "NOVEL DOPAMINE TRANSPORTER LIGANDS - THE STATE-OF-THE-ART", Medicinal chemistry research, 8(1-2), 1998, pp. 1-11
32. AMARA SG; SONDERS MS
    NEUROTRANSMITTER TRANSPORTERS AS MOLECULAR TARGETS FOR ADDICTIVE DRUGS
    Drug and alcohol dependence
    
    S.G. Amara e M.S. Sonders, "NEUROTRANSMITTER TRANSPORTERS AS MOLECULAR TARGETS FOR ADDICTIVE DRUGS", Drug and alcohol dependence, 51(1-2), 1998, pp. 87-96
33. VILLEMAGNE V; YUAN J; WONG DF; DANNALS RF; HATZIDIMITRIOU G; MATHEWS WB; RAVERT HT; MUSACHIO J; MCCANN UD; RICAURTE GA
    BRAIN DOPAMINE NEUROTOXICITY IN BABOONS TREATED WITH DOSES OF METHAMPHETAMINE COMPARABLE TO THOSE RECREATIONALLY ABUSED BY HUMANS - EVIDENCE FROM [C-11] WIN-35,428 POSITRON-EMISSION-TOMOGRAPHY STUDIES AND DIRECT IN-VITRO DETERMINATIONS
    The Journal of neuroscience
    
    V. Villemagne et al., "BRAIN DOPAMINE NEUROTOXICITY IN BABOONS TREATED WITH DOSES OF METHAMPHETAMINE COMPARABLE TO THOSE RECREATIONALLY ABUSED BY HUMANS - EVIDENCE FROM [C-11] WIN-35,428 POSITRON-EMISSION-TOMOGRAPHY STUDIES AND DIRECT IN-VITRO DETERMINATIONS", The Journal of neuroscience, 18(1), 1998, pp. 419-427
34. NORREGAARD L; FREDERIKSEN D; NIELSEN EO; GETHER U
    DELINEATION OF AN ENDOGENOUS ZINC-BINDING SITE IN THE HUMAN DOPAMINE TRANSPORTER
    EMBO journal (Print)
    
    L. Norregaard et al., "DELINEATION OF AN ENDOGENOUS ZINC-BINDING SITE IN THE HUMAN DOPAMINE TRANSPORTER", EMBO journal (Print), 17(15), 1998, pp. 4266-4273
35. SHEARMAN LP; MEYER JS
    NOREPINEPHRINE TRANSPORTERS IN RAT PLACENTA LABELED WITH [H-3]NISOXETINE
    The Journal of pharmacology and experimental therapeutics
    
    L.P. Shearman e J.S. Meyer, "NOREPINEPHRINE TRANSPORTERS IN RAT PLACENTA LABELED WITH [H-3]NISOXETINE", The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 736-743
36. WAYMENT H; MEIERGERD SM; SCHENK JO
    RELATIONSHIPS BETWEEN THE CATECHOL SUBSTRATE-BINDING SITE AND AMPHETAMINE, COCAINE, AND MAZINDOL BINDING-SITES IN A KINETIC-MODEL OF THE STRIATAL TRANSPORTER OF DOPAMINE IN-VITRO
    Journal of neurochemistry
    
    H. Wayment et al., "RELATIONSHIPS BETWEEN THE CATECHOL SUBSTRATE-BINDING SITE AND AMPHETAMINE, COCAINE, AND MAZINDOL BINDING-SITES IN A KINETIC-MODEL OF THE STRIATAL TRANSPORTER OF DOPAMINE IN-VITRO", Journal of neurochemistry, 70(5), 1998, pp. 1941-1949
37. PENADO KMY; RUDNICK G; STEPHAN MM
    CRITICAL AMINO-ACID-RESIDUES IN TRANSMEMBRANE SPAN-7 OF THE SEROTONINTRANSPORTER IDENTIFIED BY RANDOM MUTAGENESIS
    The Journal of biological chemistry
    
    K.M.Y. Penado et al., "CRITICAL AMINO-ACID-RESIDUES IN TRANSMEMBRANE SPAN-7 OF THE SEROTONINTRANSPORTER IDENTIFIED BY RANDOM MUTAGENESIS", The Journal of biological chemistry, 273(43), 1998, pp. 28098-28106
38. BARKER EL; PERLMAN MA; ADKINS EM; HOULIHAN WJ; PRISTUPA ZB; NIZNIK HB; BLAKELY RD
    HIGH-AFFINITY RECOGNITION OF SEROTONIN TRANSPORTER ANTAGONISTS DEFINED BY SPECIES-SCANNING MUTAGENESIS - AN AROMATIC RESIDUE IN TRANSMEMBRANE DOMAIN-I DICTATES SPECIES-SELECTIVE RECOGNITION OF CITALOPRAM AND MAZINDOL
    The Journal of biological chemistry
    
    E.L. Barker et al., "HIGH-AFFINITY RECOGNITION OF SEROTONIN TRANSPORTER ANTAGONISTS DEFINED BY SPECIES-SCANNING MUTAGENESIS - AN AROMATIC RESIDUE IN TRANSMEMBRANE DOMAIN-I DICTATES SPECIES-SELECTIVE RECOGNITION OF CITALOPRAM AND MAZINDOL", The Journal of biological chemistry, 273(31), 1998, pp. 19459-19468
39. Kokoshka, JM; Vaughan, RA; Hanson, GR; Fleckenstein, AE
    Nature of methamphetamine-induced rapid and reversible changes in dopaminetransporters
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    J.M. Kokoshka et al., "Nature of methamphetamine-induced rapid and reversible changes in dopaminetransporters", EUR J PHARM, 361(2-3), 1998, pp. 269-275
40. LEE SH; CHO HK; SON H; LEE YS
    SUBSTRATE TRANSPORT AND COCAINE BINDING OF HUMAN DOPAMINE TRANSPORTERIS REDUCED BY SUBSTITUTION OF CARBOXYL TAIL WITH THAT OF BOVINE DOPAMINE TRANSPORTER
    NeuroReport
    
    S.H. Lee et al., "SUBSTRATE TRANSPORT AND COCAINE BINDING OF HUMAN DOPAMINE TRANSPORTERIS REDUCED BY SUBSTITUTION OF CARBOXYL TAIL WITH THAT OF BOVINE DOPAMINE TRANSPORTER", NeuroReport, 8(11), 1997, pp. 2591-2594
41. SOUCY JP; MRINI A; LAFAILLE F; DOUCET G; DESCARRIES L
    COMPARATIVE-EVALUATION OF [H-3] WIN-35428 AND [H-3] GBR-12935 AS MARKERS OF DOPAMINE INNERVATION DENSITY IN BRAIN
    Synapse
    
    J.P. Soucy et al., "COMPARATIVE-EVALUATION OF [H-3] WIN-35428 AND [H-3] GBR-12935 AS MARKERS OF DOPAMINE INNERVATION DENSITY IN BRAIN", Synapse, 25(2), 1997, pp. 163-175
42. TELLA SR; LADENHEIM B; CADET JL
    DIFFERENTIAL REGULATION OF DOPAMINE TRANSPORTER AFTER CHRONIC SELF-ADMINISTRATION OF BUPROPION AND NOMIFENSINE
    The Journal of pharmacology and experimental therapeutics
    
    S.R. Tella et al., "DIFFERENTIAL REGULATION OF DOPAMINE TRANSPORTER AFTER CHRONIC SELF-ADMINISTRATION OF BUPROPION AND NOMIFENSINE", The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 508-513
43. WU Q; COFFEY LL; REITH MEA
    CATIONS AFFECT [H-3] MAZINDOL AND [H-3] WIN-35,428 BINDING TO THE HUMAN DOPAMINE TRANSPORTER IN A SIMILAR FASHION
    Journal of neurochemistry
    
    Q. Wu et al., "CATIONS AFFECT [H-3] MAZINDOL AND [H-3] WIN-35,428 BINDING TO THE HUMAN DOPAMINE TRANSPORTER IN A SIMILAR FASHION", Journal of neurochemistry, 69(3), 1997, pp. 1106-1118
44. REITH MEA; XU C; CHEN NH
    PHARMACOLOGY AND REGULATION OF THE NEURONAL DOPAMINE TRANSPORTER
    European journal of pharmacology
    
    M.E.A. Reith et al., "PHARMACOLOGY AND REGULATION OF THE NEURONAL DOPAMINE TRANSPORTER", European journal of pharmacology, 324(1), 1997, pp. 1-10
45. LEE SH; RHEE J; KOH JK; LEE YS
    SPECIES-DIFFERENCES IN FUNCTIONS OF DOPAMINE TRANSPORTER - PAUCITY OFMPP(+) UPTAKE AND COCAINE BINDING IN BOVINE DOPAMINE TRANSPORTER
    Neuroscience letters
    
    S.H. Lee et al., "SPECIES-DIFFERENCES IN FUNCTIONS OF DOPAMINE TRANSPORTER - PAUCITY OFMPP(+) UPTAKE AND COCAINE BINDING IN BOVINE DOPAMINE TRANSPORTER", Neuroscience letters, 214(2-3), 1996, pp. 199-201
46. REITH MEA; XU C; ZHANG LA; COFFEY LL
    TRANSLOCATION OF DOPAMINE AND BINDING OF WIN-35,428 MEASURED UNDER IDENTICAL CONDITIONS IN CELLS EXPRESSING THE CLONED HUMAN DOPAMINE TRANSPORTER
    Naunyn-Schmiedeberg's archives of pharmacology
    
    M.E.A. Reith et al., "TRANSLOCATION OF DOPAMINE AND BINDING OF WIN-35,428 MEASURED UNDER IDENTICAL CONDITIONS IN CELLS EXPRESSING THE CLONED HUMAN DOPAMINE TRANSPORTER", Naunyn-Schmiedeberg's archives of pharmacology, 354(3), 1996, pp. 295-304
47. BLOUGH BE; ABRAHAM P; LEWIN AH; KUHAR MJ; BOJA JW; CARROLL FI
    SYNTHESIS AND TRANSPORTER BINDING-PROPERTIES OF 3-BETA-(4'-ALKYL)NORTROPANE-2-BETA-CARBOXYLIC ACID, 3-BETA-(4'-ALKENYL)NORTROPANE-2-BETA-CARBOXYLIC ACID, AND ETA-(4'-ALKYNYLPHENYL)NORTROPANE-2-BETA-CARBOXYLIC ACID METHYL-ESTERS - SEROTONIN TRANSPORTER SELECTIVE ANALOGS
    Journal of medicinal chemistry
    
    B.E. Blough et al., "SYNTHESIS AND TRANSPORTER BINDING-PROPERTIES OF 3-BETA-(4'-ALKYL)NORTROPANE-2-BETA-CARBOXYLIC ACID, 3-BETA-(4'-ALKENYL)NORTROPANE-2-BETA-CARBOXYLIC ACID, AND ETA-(4'-ALKYNYLPHENYL)NORTROPANE-2-BETA-CARBOXYLIC ACID METHYL-ESTERS - SEROTONIN TRANSPORTER SELECTIVE ANALOGS", Journal of medicinal chemistry, 39(20), 1996, pp. 4027-4035
48. NEUMEYER JL; TAMAGNAN G; WANG SY; GAO YG; MILIUS RA; KULA NS; BALDESSARINI RJ
    N-SUBSTITUTED ANALOGS OF 2-BETA-CARBOMETHOXY-3-BETA-(4'-IODOPHENYL)TROPANE (BETA-CIT) WITH SELECTIVE AFFINITY TO DOPAMINE OR SEROTONIN TRANSPORTERS IN RAT FOREBRAIN
    Journal of medicinal chemistry
    
    J.L. Neumeyer et al., "N-SUBSTITUTED ANALOGS OF 2-BETA-CARBOMETHOXY-3-BETA-(4'-IODOPHENYL)TROPANE (BETA-CIT) WITH SELECTIVE AFFINITY TO DOPAMINE OR SEROTONIN TRANSPORTERS IN RAT FOREBRAIN", Journal of medicinal chemistry, 39(2), 1996, pp. 543-548
49. ALLARD P; MARCUSSON JO; ROSS SB
    [H-3] WIN 35,428 BINDING IN THE HUMAN BRAIN
    Brain research
    
    P. Allard et al., "[H-3] WIN 35,428 BINDING IN THE HUMAN BRAIN", Brain research, 706(2), 1996, pp. 347-350
50. REITH MEA; XU C; COFFEY LL
    BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE CLONED HUMAN DOPAMINE TRANSPORTER STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCEDREDUCTION OF A-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[H-3]TROPANE ([H-3]WIN-35,428) BINDING
    Biochemical pharmacology
    
    M.E.A. Reith et al., "BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE CLONED HUMAN DOPAMINE TRANSPORTER STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCEDREDUCTION OF A-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[H-3]TROPANE ([H-3]WIN-35,428) BINDING", Biochemical pharmacology, 52(9), 1996, pp. 1435-1446
51. CHEN NH; XU C; COFFEY LL; REITH MEA
    -BETA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)TROPANE] BINDING TO RAT-BRAIN MEMBRANES - COMPARING DOPAMINE CELL BODY AREAS WITH NERVE-TERMINAL REGIONS
    Biochemical pharmacology
    
    N.H. Chen et al., "-BETA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)TROPANE] BINDING TO RAT-BRAIN MEMBRANES - COMPARING DOPAMINE CELL BODY AREAS WITH NERVE-TERMINAL REGIONS", Biochemical pharmacology, 51(4), 1996, pp. 563-566
52. VOLKOW ND; WANG GJ; GATLEY SJ; FOWLER JS; DING YS; LOGAN J; HITZEMANN R; ANGRIST B; LIEBERMAN J
    TEMPORAL RELATIONSHIPS BETWEEN THE PHARMACOKINETICS OF METHYLPHENIDATE IN THE HUMAN BRAIN AND ITS BEHAVIORAL AND CARDIOVASCULAR EFFECTS
    Psychopharmacology
    
    N.D. Volkow et al., "TEMPORAL RELATIONSHIPS BETWEEN THE PHARMACOKINETICS OF METHYLPHENIDATE IN THE HUMAN BRAIN AND ITS BEHAVIORAL AND CARDIOVASCULAR EFFECTS", Psychopharmacology, 123(1), 1996, pp. 26-33
53. MULLER L; HALL H; HALLDIN C; FARDE L; HOHLWEG R; SUZDAK PD; NIELSEN EB; FOGED C
    SYNTHESIS AND BINDING-PROPERTIES OF [H-3]NNC-12-0781, A NEW RADIOLIGAND FOR THE DOPAMINE REUPTAKE SYSTEM
    Nuclear medicine and biology
    
    L. Muller et al., "SYNTHESIS AND BINDING-PROPERTIES OF [H-3]NNC-12-0781, A NEW RADIOLIGAND FOR THE DOPAMINE REUPTAKE SYSTEM", Nuclear medicine and biology, 22(6), 1995, pp. 711-717
54. VALCHAR M; HANBAUER I
    RAT MESENCEPHALIC NEURONAL CELLS CULTURED FOR DIFFERENT PERIODS AS A MODEL OF DOPAMINE TRANSPORTER ONTOGENY
    Molecular neurobiology
    
    M. Valchar e I. Hanbauer, "RAT MESENCEPHALIC NEURONAL CELLS CULTURED FOR DIFFERENT PERIODS AS A MODEL OF DOPAMINE TRANSPORTER ONTOGENY", Molecular neurobiology, 11(1-3), 1995, pp. 111-119
55. GATLEY SJ; VOLKOW ND; FOWLER JS; DEWEY SL; LOGAN J
    SENSITIVITY OF STRIATAL [C-11] COCAINE BINDING TO DECREASES IN SYNAPTIC DOPAMINE
    Synapse
    
    S.J. Gatley et al., "SENSITIVITY OF STRIATAL [C-11] COCAINE BINDING TO DECREASES IN SYNAPTIC DOPAMINE", Synapse, 20(2), 1995, pp. 137-144
56. VOLKOW ND; DING YS; FOWLER JS; WANG GJ; LOGAN J; GATLEY SJ; SCHLYER DJ; PAPPAS N
    A NEW PET LIGAND FOR THE DOPAMINE TRANSPORTER - STUDIES IN THE HUMAN BRAIN
    The Journal of nuclear medicine
    
    N.D. Volkow et al., "A NEW PET LIGAND FOR THE DOPAMINE TRANSPORTER - STUDIES IN THE HUMAN BRAIN", The Journal of nuclear medicine, 36(12), 1995, pp. 2162-2168
57. MALISON RT; VESSOTSKIE JM; KUNG MP; MCELGIN W; ROMANIELLO G; KIM HJ; GOODMAN MM; KUNG HF
    STRIATAL DOPAMINE TRANSPORTER IMAGING IN NONHUMAN-PRIMATES WITH IODINE-123-IPT SPECT
    The Journal of nuclear medicine
    
    R.T. Malison et al., "STRIATAL DOPAMINE TRANSPORTER IMAGING IN NONHUMAN-PRIMATES WITH IODINE-123-IPT SPECT", The Journal of nuclear medicine, 36(12), 1995, pp. 2290-2297
58. BOJA JW; CADET JL; KOPAJTIC TA; LEVER J; SELTZMAN HH; WYRICK CD; LEWIN AH; ABRAHAM P; CARROLL FI
    SELECTIVE LABELING OF THE DOPAMINE TRANSPORTER BY THE HIGH-AFFINITY LIGAND ETA-(4-[I-125]IODOPHENYL)TROPANE-2-BETA-CARBOXYLIC ACID ISOPROPYL ESTER
    Molecular pharmacology
    
    J.W. Boja et al., "SELECTIVE LABELING OF THE DOPAMINE TRANSPORTER BY THE HIGH-AFFINITY LIGAND ETA-(4-[I-125]IODOPHENYL)TROPANE-2-BETA-CARBOXYLIC ACID ISOPROPYL ESTER", Molecular pharmacology, 47(4), 1995, pp. 779-786
59. WANG GJ; VOLKOW ND; FOWLER JS; DING YS; LOGAN J; GATLEY SJ; MACGREGOR RR; WOLF AP
    COMPARISON OF 2 PET RADIOLIGANDS FOR IMAGING EXTRASTRIATAL DOPAMINE TRANSPORTERS IN HUMAN BRAIN
    Life sciences
    
    G.J. Wang et al., "COMPARISON OF 2 PET RADIOLIGANDS FOR IMAGING EXTRASTRIATAL DOPAMINE TRANSPORTERS IN HUMAN BRAIN", Life sciences, 57(14), 1995, pp. 187-191
60. COULTER CL; HAPPE HK; BERGMAN DA; MURRIN LC
    LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55
    Brain research
    
    C.L. Coulter et al., "LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55", Brain research, 690(2), 1995, pp. 217-224
61. SCAVONE C; MCKEE M; NATHANSON JA
    MONOAMINE UPTAKE IN INSECT SYNAPTOSOMAL PREPARATIONS
    Insect biochemistry and molecular biology
    
    C. Scavone et al., "MONOAMINE UPTAKE IN INSECT SYNAPTOSOMAL PREPARATIONS", Insect biochemistry and molecular biology, 24(6), 1994, pp. 589-597
62. KITAYAMA S; DOHI T; UHL GR
    PHORBOL ESTERS ALTER FUNCTIONS OF THE EXPRESSED DOPAMINE TRANSPORTER
    European journal of pharmacology. Molecular pharmacology section
    
    S. Kitayama et al., "PHORBOL ESTERS ALTER FUNCTIONS OF THE EXPRESSED DOPAMINE TRANSPORTER", European journal of pharmacology. Molecular pharmacology section, 268(2), 1994, pp. 115-119
63. DING YS; FOWLER JS; VOLKOW ND; GATLEY SJ; LOGAN J; DEWEY SL; ALEXOFF D; FAZZINI E; WOLF AP
    PHARMACOKINETICS AND IN-VIVO SPECIFICITY OF [C-11] DL-THREO-METHYLPHENIDATE FOR THE PRESYNAPTIC DOPAMINERGIC NEURON
    Synapse
    
    Y.S. Ding et al., "PHARMACOKINETICS AND IN-VIVO SPECIFICITY OF [C-11] DL-THREO-METHYLPHENIDATE FOR THE PRESYNAPTIC DOPAMINERGIC NEURON", Synapse, 18(2), 1994, pp. 152-160
64. SCHWERI MM
    MERCURIC-CHLORIDE AND P-CHLOROMERCURIPHENYLSULFONATE EXERT A BIPHASICEFFECT ON THE BINDING OF THE STIMULANT [H-3] METHYLPHENIDATE TO THE DOPAMINE TRANSPORTER
    Synapse
    
    M.M. Schweri, "MERCURIC-CHLORIDE AND P-CHLOROMERCURIPHENYLSULFONATE EXERT A BIPHASICEFFECT ON THE BINDING OF THE STIMULANT [H-3] METHYLPHENIDATE TO THE DOPAMINE TRANSPORTER", Synapse, 16(3), 1994, pp. 188-194
65. DERSCH CM; AKUNNE HC; PARTILLA JS; CHAR GU; DECOSTA BR; RICE KC; CARROLL FI; ROTHMAN RB
    STUDIES OF THE BIOGENIC-AMINE TRANSPORTERS .1. DOPAMINE REUPTAKE BLOCKERS INHIBIT [H-3] MAZINDOL BINDING TO THE DOPAMINE TRANSPORTER BY A COMPETITIVE MECHANISM - PRELIMINARY EVIDENCE FOR DIFFERENT BINDING DOMAINS
    Neurochemical research
    
    C.M. Dersch et al., "STUDIES OF THE BIOGENIC-AMINE TRANSPORTERS .1. DOPAMINE REUPTAKE BLOCKERS INHIBIT [H-3] MAZINDOL BINDING TO THE DOPAMINE TRANSPORTER BY A COMPETITIVE MECHANISM - PRELIMINARY EVIDENCE FOR DIFFERENT BINDING DOMAINS", Neurochemical research, 19(2), 1994, pp. 201-208
66. HITRI A; HURD YL; WYATT RJ; DEUTSCH SI
    MOLECULAR, FUNCTIONAL AND BIOCHEMICAL CHARACTERISTICS OF THE DOPAMINETRANSPORTER - REGIONAL DIFFERENCES AND CLINICAL RELEVANCE
    Clinical neuropharmacology
    
    A. Hitri et al., "MOLECULAR, FUNCTIONAL AND BIOCHEMICAL CHARACTERISTICS OF THE DOPAMINETRANSPORTER - REGIONAL DIFFERENCES AND CLINICAL RELEVANCE", Clinical neuropharmacology, 17(1), 1994, pp. 1-22
67. MULLER L; HALLDIN C; FOGED C; KARLSSON P; HALL H; SWAHN CG; SUZDAK PD; HOHLWEG R; NIELSEN EB; FARDE L
    PREPARATION OF A POTENTIAL POSITRON EMISSION TOMOGRAPHIC RADIOLIGAND FOR THE DOPAMINE TRANSPORTER
    European journal of nuclear medicine
    
    L. Muller et al., "PREPARATION OF A POTENTIAL POSITRON EMISSION TOMOGRAPHIC RADIOLIGAND FOR THE DOPAMINE TRANSPORTER", European journal of nuclear medicine, 21(2), 1994, pp. 131-137
68. PRISTUPA ZB; WILSON JM; HOFFMAN BJ; KISH SJ; NIZNIK HB
    PHARMACOLOGICAL HETEROGENEITY OF THE CLONED AND NATIVE HUMAN DOPAMINETRANSPORTER - DISASSOCIATION OF [H-3] WIN 35,428 AND [H-3] GBR 12,935BINDING
    Molecular pharmacology
    
    Z.B. Pristupa et al., "PHARMACOLOGICAL HETEROGENEITY OF THE CLONED AND NATIVE HUMAN DOPAMINETRANSPORTER - DISASSOCIATION OF [H-3] WIN 35,428 AND [H-3] GBR 12,935BINDING", Molecular pharmacology, 45(1), 1994, pp. 125-135
69. GOODMAN MM; KUNG MP; KABALKA GW; KUNG HF; SWITZER R
    SYNTHESIS AND CHARACTERIZATION OF RADIOIODINATED -BETA-CARBOMETHOXY-3-BETA-(4-CHLOROPHENYL)TROPANES - POTENTIAL DOPAMINE REUPTAKE SITE IMAGING AGENTS
    Journal of medicinal chemistry
    
    M.M. Goodman et al., "SYNTHESIS AND CHARACTERIZATION OF RADIOIODINATED -BETA-CARBOMETHOXY-3-BETA-(4-CHLOROPHENYL)TROPANES - POTENTIAL DOPAMINE REUPTAKE SITE IMAGING AGENTS", Journal of medicinal chemistry, 37(10), 1994, pp. 1535-1542
70. BALDWIN RM; ZEAPONCE Y; ZOGHBI SS; LAURELLE M; ALTIKRITI MS; SYBIRSKA EH; MALISON RT; NEUMEYER JL; MILIUS RA; WANG SY; STABIN M; SMITH EO; CHARNEY DS; HOFFER PB; INNIS RB
    EVALUATION OF THE MONOAMINE UPTAKE SITE LIGAND [I-123] METHYL 3-BETA-(4-IODOPHENYL)-TROPANE-2-BETA-CARBOXYLATE ([I-123)BETA-CIT) IN NONHUMAN-PRIMATES - PHARMACOKINETICS, BIODISTRIBUTION AND SPECT BRAIN IMAGINGCOREGISTERED WITH MRI
    Nuclear medicine and biology
    
    R.M. Baldwin et al., "EVALUATION OF THE MONOAMINE UPTAKE SITE LIGAND [I-123] METHYL 3-BETA-(4-IODOPHENYL)-TROPANE-2-BETA-CARBOXYLATE ([I-123)BETA-CIT) IN NONHUMAN-PRIMATES - PHARMACOKINETICS, BIODISTRIBUTION AND SPECT BRAIN IMAGINGCOREGISTERED WITH MRI", Nuclear medicine and biology, 20(5), 1993, pp. 597-606
71. WONG DF; YUNG B; DANNALS RF; SHAYA EK; RAVERT HT; CHEN CA; CHAN B; FOLIO T; SCHEFFEL U; RICAURTE GA; NEUMEYER JL; WAGNER HN; KUHAR MJ
    IN-VIVO IMAGING OF BABOON AND HUMAN DOPAMINE TRANSPORTERS BY POSITRONEMISSION TOMOGRAPHY USING [C-11] WIN-35,428
    Synapse
    
    D.F. Wong et al., "IN-VIVO IMAGING OF BABOON AND HUMAN DOPAMINE TRANSPORTERS BY POSITRONEMISSION TOMOGRAPHY USING [C-11] WIN-35,428", Synapse, 15(2), 1993, pp. 130-142
72. AUGOOD SJ; WESTMORE K; MCKENNA PJ; EMSON PC
    COEXPRESSION OF DOPAMINE TRANSPORTER MESSENGER-RNA AND TYROSINE-HYDROXYLASE MESSENGER-RNA IN VENTRAL MESENCEPHALIC NEURONS
    Molecular brain research
    
    S.J. Augood et al., "COEXPRESSION OF DOPAMINE TRANSPORTER MESSENGER-RNA AND TYROSINE-HYDROXYLASE MESSENGER-RNA IN VENTRAL MESENCEPHALIC NEURONS", Molecular brain research, 20(4), 1993, pp. 328-334
73. ESHLEMAN AJ; CALLIGARO DO; ELDEFRAWI ME
    ALLOSTERIC REGULATION BY SODIUM OF THE BINDING OF [H-3] COCAINE AND [H-3] GBR-12935 TO RAT AND BOVINE STRIATA
    Membrane biochemistry
    
    A.J. Eshleman et al., "ALLOSTERIC REGULATION BY SODIUM OF THE BINDING OF [H-3] COCAINE AND [H-3] GBR-12935 TO RAT AND BOVINE STRIATA", Membrane biochemistry, 10(3), 1993, pp. 129-144
74. KIM KH; BASHA F; HANCOCK A; DEBERNARDIS JF
    QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS FOR SUBSTITUTED AMINOTETRALIN ANALOGS .2. INHIBITION OF DOPAMINE UPTAKE
    Journal of pharmaceutical sciences
    
    K.H. Kim et al., "QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS FOR SUBSTITUTED AMINOTETRALIN ANALOGS .2. INHIBITION OF DOPAMINE UPTAKE", Journal of pharmaceutical sciences, 82(5), 1993, pp. 521-525